We are live on ! Find out more
NSEDCP

NJ State Employees Deferred Compensation Plan Portfolio holdings

AUM $906M
1-Year Est. Return 24.85%
This Fund
S&P 500
This Quarter Est. Return
+9.44%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$693M
AUM Growth
+$45.3M
Cap. Flow
-$3.57M
Cap. Flow %
-0.52%
Top 10 Hldgs %
27.41%
Holding
501
New
6
Increased
–
Reduced
6
Closed
14

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$2M
2
PPLI
People Inc
PPLI
+$216K
3
VMW
VMware, Inc
VMW
+$207K
4
CCOI icon
Cogent Communications
CCOI
+$196K
5
VSAT icon
Viasat
VSAT
+$194K

Top Sells

Rank Stock Value
1
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$1.61M
2
APEN
Apollo Endosurgery, Inc.
APEN
+$1.29M
3
MGI
MoneyGram International, Inc. New
MGI
+$1.04M
4
TA
TravelCenters of America LLC
TA
+$865K
5
HSKA
Heska Corp
HSKA
+$683K

Sector Composition

Rank Sector Weight
1 Technology 28.14%
2 Healthcare 14.27%
3 Industrials 11.75%
4 Financials 10.7%
5 Consumer Discretionary 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTAP icon
326
NetApp
NTAP
$37.3B
$382K 0.06%
5,000
– –
FULT icon
327
Fulton Financial
FULT
$4.76B
$381K 0.06%
32,000
– –
WWE
328
DELISTED
World Wrestling Entertainment
WWE
$380K 0.05%
3,500
– –
ILMN icon
329
Illumina
ILMN
$29.9B
$375K 0.05%
2,056
– –
ARWR icon
330
Arrowhead Research
ARWR
$12.4B
$374K 0.05%
10,500
– –
NTRS icon
331
Northern Trust
NTRS
$33.6B
$371K 0.05%
5,000
– –
C icon
332
Citigroup
C
$231B
$368K 0.05%
8,000
– –
SFBS
333
ServisFirst Bancshares
SFBS
$4.97B
$368K 0.05%
9,000
– –
FHN icon
334
First Horizon
FHN
$12.4B
$362K 0.05%
32,088
– –
LGND icon
335
Ligand Pharmaceuticals
LGND
$5.95B
$361K 0.05%
5,000
– –
REGN icon
336
Regeneron Pharmaceuticals
REGN
$77.9B
$359K 0.05%
500
– –
LNN icon
337
Lindsay Corp
LNN
$1.19B
$358K 0.05%
3,000
– –
SF
338
Stifel
SF
$12.8B
$358K 0.05%
9,000
– –
TRUP icon
339
Trupanion
TRUP
$1.07B
$354K 0.05%
18,000
– –
TITN icon
340
Titan Machinery
TITN
$443M
$354K 0.05%
12,000
– –
VRTX icon
341
Vertex Pharmaceuticals
VRTX
$121B
$352K 0.05%
1,000
– –
MTCH icon
342
Match Group
MTCH
$9.62B
$350K 0.05%
8,363
– –
ATEX icon
343
Anterix
ATEX
$1.98B
$349K 0.05%
11,000
– –
NSA
344
DELISTED
National Storage Affiliates Trust
NSA
$348K 0.05%
10,000
– –
IPG
345
DELISTED
Interpublic Group of Companies
IPG
$347K 0.05%
9,000
– –
MDGL icon
346
Madrigal Pharmaceuticals
MDGL
$11.6B
$347K 0.05%
1,500
– –
INFN
347
DELISTED
Infinera Corporation Common Stock
INFN
$338K 0.05%
70,000
– –
HAIN icon
348
Hain Celestial
HAIN
$45.8M
$338K 0.05%
27,000
– –
LGF.B
349
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$334K 0.05%
40,000
– –
FTI icon
350
TechnipFMC
FTI
$27.7B
$332K 0.05%
20,000
– –
12 13
14
15 16

Similar funds

IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
BFS
Bard Financial Services Branford, Connecticut $911M AUM 19.14% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
CP
Coho Partners Berwyn, Pennsylvania $779M AUM 4.46% 1-Year Est. Return
EAM
EFG Asset Management Portland, Oregon $773M AUM 40.1% 1-Year Est. Return
HWM
Hemington Wealth Management Falls Church, Virginia $769M AUM 13.16% 1-Year Est. Return
BVDMP
Bedrijfstakpensioenfonds Voor De Media PNO Hilversum, Netherlands $759M AUM 19.37% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's Q2 2023 Portfolio in Review

As of Q2 2023, NJ State Employees Deferred Compensation Plan held 501 positions worth $693M, up 7% from $648M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 4%. NJ State Employees Deferred Compensation Plan opened 6 new positions and exited 14, leaving the 501-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Industrials.

  • NJ State Employees Deferred Compensation Plan's largest Q2 2023 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 19,000 shares worth $1.95M.
  • NJ State Employees Deferred Compensation Plan's biggest Q2 2023 reduction was Concentrix, cutting an estimated $88.6K.
  • NJ State Employees Deferred Compensation Plan fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $1.61M.
  • NJ State Employees Deferred Compensation Plan's ten largest holdings make up 27% of its $693M portfolio in Q2 2023.
  • NJ State Employees Deferred Compensation Plan opened 6 new positions and closed 14 in Q2 2023.
  • NJ State Employees Deferred Compensation Plan's portfolio value rose 7% quarter-over-quarter to $693M.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q2 2023, filed 2 Aug 2023.